The global hormone replacement therapy market size was US$ 32.1 billion in 2021. The global hormone replacement therapy market is forecast to grow to US$ 51.1 billion by 2030 by growing at a compound annual growth rate CAGR of 6.1% during the forecast period from 2022 to 2030.

Hormonal replacement therapy (HRT) is a widely adopted method to cure problems or diseases related to the deficiency of a particular hormone. The hormone is available in various forms, such as transdermal, gels, injections, implants, tablets, and other forms.

Factors Influencing the Market

Hormone replacement therapy is widely suggested for people suffering from hypogonadism or other hormonal disorders. Thus, the growing prevalence of these disorders will fuel the growth of the global hormone replacement therapy market. In addition to that, the growing cases of menopause in women are likely to have a positive impact on the hormone replacement therapy market globally.

Growing concerns related to animals and plants will fuel the growth of the market. Hormones are injected into animals in order to decrease the gestation period. In addition, it also increases milk production and quality of meat, which will contribute to the growth of the global hormone replacement therapy market.

Ongoing R&D studies and the growing number of advancements in technology or healthcare will offer ample growth opportunities for the global hormone replacement therapy market.

The risk associated with the therapy, such as stroke, cancer, weight gain, or loss, may limit the market growth during the forecast period.

COVID-19 Impact Analysis

The wake of the COVID-9 pandemic marked potential growth for the global hormone replacement therapy market. Due to the pandemic, people became more aware of their health. In addition, a growing number of incidences related to hormonal imbalance surged the demand for efficient therapies. As a result, the global hormone replacement therapy market witnessed substantial growth. Moreover, estrogen is highly efficient in enhancing the immune response. Thus, all of these facts accelerated the growth of the market during the COVID-19 pandemic period.

Regional Analysis

North America is forecast to dominate the global hormone replacement therapy market. The growth of the market is attributed to the high healthcare expenditure and growing prevalence of diseases related to hormonal imbalance. In addition, high disposable incomes and a growing employment rate will significantly contribute to the growth of the market during the study period.

Competitors in the Market

Abbott Laboratories
Bayer AG
Eli Lilly and company
F. Hoffmann-La Roche Ltd
Hisamitsu Pharmaceutical co. Inc.
Merck KGaA
Mylan N.V.
Pfizer Inc.
Novartis International AG
Other Prominent Players
Market Segmentation

The global hormone replacement therapy market segmentation focuses on Therapies, Indication, Route administration, and Region.

Based on the therapies type, the hormone replacement therapy market has been segmented into

Estrogen HRT
Human growth HRT
Thyroid HRT
Testosterone HRT
Progestogen HRT
Based on the indication, the hormone replacement therapy market has been segmented into

Menopause
Hypothyroidism
Male Hypogonadism
Growth Hormone Deficiency
Others
Based on the route administration, the hormone replacement therapy market has been segmented into-

Oral
Parenteral
Transdermal
Others
Based on the region, the hormone replacement therapy market has been segmented into-

North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Brazil
Argentina
Rest of South America